Overview
News
Technologies
Salaries
Products
People
Growth
Financials

Overview

Logomix is a Japan-based synthetic biology company that develops genome engineering technologies for human cells. Its Geno-Writing platform enables precise engineering of megabase-scale genomic sequences directly within human cells, allowing creation of super-functionalized cells. Logomix positions these engineered cells for applications in cell therapy, regenerative medicine and other future cell-based therapeutics.